RxDoctor Payments Data

Michael Ferguson

Pediatric Hematology-Oncology · Louisville, KYNPI 1376701102

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,128 of the $3,325 with a category attached, or 94.1%. Bayer accounts for 94.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $2,278 and has fallen 93.5% since, to $147 in 2025.

$3,325in general payments, 2019–2025

Across 7 payments — averaging $474.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$3K
  • Amgen$128
  • Jazz Pharmaceuticals Inc.$27
  • Pfizer$26
  • Day One Biopharmaceuticals$16
$2,995,087in research payments, 2019–2025

Across 94 payments — averaging $31,863 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2.7M
  • Pfizer$184K
  • Merck$63K
  • AstraZeneca$57K
  • AbbVie$118

What the payments were for

  • Consulting fees$3,12894%
  • Food & beverage$1976%

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →